The new cleanroom at our global headquarters in Salt Lake City, Utah, was designed for today's rigorous contamination control expectations, driven by EU GMP Annex 1. Learn More
Drug products and medical device extracts are chromatographically analysed via non-targeted analysis to detect, identify, and quantify organic leachables; GC/MS addresses primarily volatile and semi-volatile organic leachables. Identities of compounds detected by GC/MS are often secured by mass spectral matching...
This is the final part of the IV-part whitepaper series that describes the aspect of identification and, more specifically, on the process by which mass spectral data and other supporting evidence are used to secure, judge and justify complete and...
This is part III OF a IV-part whitepaper series that describes the aspect of identification and, more specifically, on the process by which mass spectral data and other supporting evidence are used to secure, judge and justify complete and correct...
This is part II OF a IV-part whitepaper series that discribes the aspect of identification and, more specifically, on the process by which mass spectral data and other supporting evidence are used to secure, judge and justify complete and correct...
This series of white papers focus on the aspect of identification and, more specifically, on the process by which mass spectral data and other supporting evidence are used to secure, judge and justify complete and correct identities for all relevant...
